Kumar et al. [54] addressed this issue in their review, which described HSP70’s role as an immunomodulator, proteolytic pathway gatekeeper, and regulator of apoptosis, calling it a potential therapeutic target for AMD. This evidence concerns the gene HSPA4 and age-related macular degeneration.